1. Home
  2. OOMA vs BCYC Comparison

OOMA vs BCYC Comparison

Compare OOMA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$14.41

Market Cap

408.2M

Sector

Technology

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.99

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
BCYC
Founded
2003
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.2M
360.7M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
OOMA
BCYC
Price
$14.41
$4.99
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$18.77
$14.00
AVG Volume (30 Days)
232.2K
567.5K
Earning Date
05-27-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
188.46
N/A
EPS
0.23
N/A
Revenue
$114,490,000.00
N/A
Revenue This Year
$20.35
N/A
Revenue Next Year
$3.82
N/A
P/E Ratio
$63.65
N/A
Revenue Growth
9.53
N/A
52 Week Low
$9.79
$4.24
52 Week High
$15.15
$9.55

Technical Indicators

Market Signals
Indicator
OOMA
BCYC
Relative Strength Index (RSI) 58.68 50.38
Support Level $10.95 $4.24
Resistance Level $14.83 $7.14
Average True Range (ATR) 0.50 0.29
MACD -0.04 0.09
Stochastic Oscillator 56.32 81.56

Price Performance

Historical Comparison
OOMA
BCYC

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: